Posted by Michael Wonder on 08 Oct 2018
Valneva announces FDA approval of accelerated Ixiario vaccination schedule
5 October 2018 - Valneva announced today that the U.S. FDA has approved an alternate Ixiaro immunisation schedule of two doses administered seven days apart for adult travellers aged 18-65 years old.
This accelerated schedule comes in addition to the previously approved schedule.
The FDA’s revised schedule follows previous approvals by Health Canada and the European Medicines Agency, who authorised accelerated Ixiaro vaccination schedules for adult travellers in March 2018 and April 2015, respectively.
